These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 10822385

  • 1. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.
    Hermisson M, Wagenknecht B, Wolburg H, Glaser T, Dichgans J, Weller M.
    Oncogene; 2000 May 04; 19(19):2338-45. PubMed ID: 10822385
    [Abstract] [Full Text] [Related]

  • 2. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M, Weller M.
    Cell Death Differ; 2003 Sep 04; 10(9):1078-89. PubMed ID: 12934082
    [Abstract] [Full Text] [Related]

  • 3. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
    Röhn TA, Wagenknecht B, Roth W, Naumann U, Gulbins E, Krammer PH, Walczak H, Weller M.
    Oncogene; 2001 Jul 12; 20(31):4128-37. PubMed ID: 11464279
    [Abstract] [Full Text] [Related]

  • 4. Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing.
    Wagenknecht B, Schulz JB, Gulbins E, Weller M.
    Cell Death Differ; 1998 Oct 12; 5(10):894-900. PubMed ID: 10203695
    [Abstract] [Full Text] [Related]

  • 5. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S, Meyer E, Debatin KM.
    Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673
    [Abstract] [Full Text] [Related]

  • 6. Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells.
    Glaser T, Wagenknecht B, Weller M.
    Oncogene; 2001 Aug 09; 20(35):4757-67. PubMed ID: 11521188
    [Abstract] [Full Text] [Related]

  • 7. C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis.
    Wagenknecht B, Roth W, Gulbins E, Wolburg H, Weller M.
    Cell Death Differ; 2001 Jun 09; 8(6):595-602. PubMed ID: 11536010
    [Abstract] [Full Text] [Related]

  • 8. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K, Douglas L, Delaney A, Houghton JA.
    Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455
    [Abstract] [Full Text] [Related]

  • 9. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Dec 15; 60(24):7149-55. PubMed ID: 11156424
    [Abstract] [Full Text] [Related]

  • 10. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
    Walczak H, Bouchon A, Stahl H, Krammer PH.
    Cancer Res; 2000 Jun 01; 60(11):3051-7. PubMed ID: 10850456
    [Abstract] [Full Text] [Related]

  • 11. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM, Wang Y, Weber RL, Sperfslage BJ, Lou K, Crossland J, Hua DH, Perchellet JP.
    Biochem Pharmacol; 2004 Feb 01; 67(3):523-37. PubMed ID: 15037204
    [Abstract] [Full Text] [Related]

  • 12. CD95-mediated apoptosis of human glioma cells: modulation by epidermal growth factor receptor activity.
    Steinbach JP, Supra P, Huang HJ, Cavenee WK, Weller M.
    Brain Pathol; 2002 Jan 01; 12(1):12-20. PubMed ID: 11770895
    [Abstract] [Full Text] [Related]

  • 13. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
    Ng CP, Zisman A, Bonavida B.
    Prostate; 2002 Dec 01; 53(4):286-99. PubMed ID: 12430140
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells.
    Sun SY, Yue P, Zhou JY, Wang Y, Choi Kim HR, Lotan R, Wu GS.
    Biochem Biophys Res Commun; 2001 Jan 26; 280(3):788-97. PubMed ID: 11162590
    [Abstract] [Full Text] [Related]

  • 15. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A, Lam A, Datta R, Srivastava RK.
    Oncogene; 2001 Apr 19; 20(17):2122-33. PubMed ID: 11360196
    [Abstract] [Full Text] [Related]

  • 16. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
    Izeradjene K, Douglas L, Tillman DM, Delaney AB, Houghton JA.
    Cancer Res; 2005 Aug 15; 65(16):7436-45. PubMed ID: 16103097
    [Abstract] [Full Text] [Related]

  • 17. Failure of Bcl-2 to block mitochondrial dysfunction during TRAIL-induced apoptosis. Tumor necrosis-related apoptosis-inducing ligand.
    Kim EJ, Suliman A, Lam A, Srivastava RK.
    Int J Oncol; 2001 Jan 15; 18(1):187-94. PubMed ID: 11115558
    [Abstract] [Full Text] [Related]

  • 18. Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2.
    Murphy KM, Streips UN, Lock RB.
    Oncogene; 1999 Oct 28; 18(44):5991-9. PubMed ID: 10557088
    [Abstract] [Full Text] [Related]

  • 19. Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L protein expression.
    Winter S, Weller M.
    J Pharmacol Exp Ther; 1998 Sep 28; 286(3):1374-82. PubMed ID: 9732400
    [Abstract] [Full Text] [Related]

  • 20. Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells.
    Glaser T, Wagenknecht B, Groscurth P, Krammer PH, Weller M.
    Oncogene; 1999 Sep 09; 18(36):5044-53. PubMed ID: 10490841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.